A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels

Evan R. Ferguson, Benita S. Katzenellenbogen, Evan R. Ferguson

Research output: Contribution to journalArticle

Abstract

Studies were undertaken to ascertain the effects of structural modification of two well-known antiestrogens (CI-628 and U-ll,100A) on their estrogenic and antiestrogenic potencies and temporal patterns of effectiveness in the immature rat uterus. Changes in the chemical structures of these antiestrogens produce compounds with markedly different affinities for the uterine estrogen receptor as measured in an in vitro cell-free cytosol system; binding affinities relative to estradiol (100%) are: CI-628, 4% CI-680, 34% 94X1127 (94X), 222% U-ll,100A (UA), 6% and U-23,469 (U-23), 0.1%. Although all five antiestrogens (daily injections of 50 μg over three days) appear equally effective in stimulating 72 h uterine weight when given alone, or in blocking the estradiol-stimulated weight increase when given with estradiol, marked differences in their potencies are noted when the effects of the compounds are monitored beyond 24 h following a single injection. The compounds CI-628, CI-680 and UA (50 μg sc in saline), which have a methylated hydroxyl group (at the site analogous to the steroid position 3), show a prolonged maintenance of elevated levels of nuclear receptor (beyond 48 h) and elevated uterine weight (until 72 h); this correlates with a prolonged period of depressed cytoplasmic receptor levels (beyond 48 h) and prolonged uterine insensitivity to estrogen (beyond 36 h as monitored by 3 h wet weight response). In contrast, a single injection of 50 μg of 94X (having a free hydroxyl group) or U-23 (with a side chain and central ring different from UA) maintained nuclear receptor levels elevated for only 12 h (94X) or 36 h (U-23) and uterine weights declined after 36-48 h; cytoplasmic receptor levels remained depressed for only 12 h (94X) or 24 h (U-23) and then returned to control levels or above by 36 h. These latter compounds likewise evoked the shortest period of uterine insensitivity to estrogen (ineffective as antagonists by 36 h). Comparative studies with these five compounds indicate that they are effective as estrogen antagonists only so long as they maintain cytoplasmic receptor levels low, and that the magnitude of the responsiveness to estradiol after antiestrogen correlates with the extent of reappearance of cytoplasmic receptor. Thus, chemical modifications of antiestrogen structure have significant effects on their temporal patterns of effectiveness as estrogens and as estrogen antagonists.

Original languageEnglish (US)
Pages (from-to)1242-1251
Number of pages10
JournalEndocrinology
Volume100
Issue number5
DOIs
StatePublished - May 1977
Externally publishedYes

Fingerprint

Estrogen Receptor Modulators
Cytoplasmic and Nuclear Receptors
Estrogen Receptors
Nitromifene
Estrogens
Estradiol
Weights and Measures
Growth
Estrogen Antagonists
Hydroxyl Radical
Injections
Cell-Free System
Cytosol
Uterus
Steroids
Maintenance

ASJC Scopus subject areas

  • Endocrinology

Cite this

A comparative study of antiestrogen action : temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels. / Ferguson, Evan R.; Katzenellenbogen, Benita S.; Ferguson, Evan R.

In: Endocrinology, Vol. 100, No. 5, 05.1977, p. 1242-1251.

Research output: Contribution to journalArticle

@article{502204da3fde45afbebcb0a63940394b,
title = "A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels",
abstract = "Studies were undertaken to ascertain the effects of structural modification of two well-known antiestrogens (CI-628 and U-ll,100A) on their estrogenic and antiestrogenic potencies and temporal patterns of effectiveness in the immature rat uterus. Changes in the chemical structures of these antiestrogens produce compounds with markedly different affinities for the uterine estrogen receptor as measured in an in vitro cell-free cytosol system; binding affinities relative to estradiol (100{\%}) are: CI-628, 4{\%} CI-680, 34{\%} 94X1127 (94X), 222{\%} U-ll,100A (UA), 6{\%} and U-23,469 (U-23), 0.1{\%}. Although all five antiestrogens (daily injections of 50 μg over three days) appear equally effective in stimulating 72 h uterine weight when given alone, or in blocking the estradiol-stimulated weight increase when given with estradiol, marked differences in their potencies are noted when the effects of the compounds are monitored beyond 24 h following a single injection. The compounds CI-628, CI-680 and UA (50 μg sc in saline), which have a methylated hydroxyl group (at the site analogous to the steroid position 3), show a prolonged maintenance of elevated levels of nuclear receptor (beyond 48 h) and elevated uterine weight (until 72 h); this correlates with a prolonged period of depressed cytoplasmic receptor levels (beyond 48 h) and prolonged uterine insensitivity to estrogen (beyond 36 h as monitored by 3 h wet weight response). In contrast, a single injection of 50 μg of 94X (having a free hydroxyl group) or U-23 (with a side chain and central ring different from UA) maintained nuclear receptor levels elevated for only 12 h (94X) or 36 h (U-23) and uterine weights declined after 36-48 h; cytoplasmic receptor levels remained depressed for only 12 h (94X) or 24 h (U-23) and then returned to control levels or above by 36 h. These latter compounds likewise evoked the shortest period of uterine insensitivity to estrogen (ineffective as antagonists by 36 h). Comparative studies with these five compounds indicate that they are effective as estrogen antagonists only so long as they maintain cytoplasmic receptor levels low, and that the magnitude of the responsiveness to estradiol after antiestrogen correlates with the extent of reappearance of cytoplasmic receptor. Thus, chemical modifications of antiestrogen structure have significant effects on their temporal patterns of effectiveness as estrogens and as estrogen antagonists.",
author = "Ferguson, {Evan R.} and Katzenellenbogen, {Benita S.} and Ferguson, {Evan R.}",
year = "1977",
month = "5",
doi = "10.1210/endo-100-5-1242",
language = "English (US)",
volume = "100",
pages = "1242--1251",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - A comparative study of antiestrogen action

T2 - temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels

AU - Ferguson, Evan R.

AU - Katzenellenbogen, Benita S.

AU - Ferguson, Evan R.

PY - 1977/5

Y1 - 1977/5

N2 - Studies were undertaken to ascertain the effects of structural modification of two well-known antiestrogens (CI-628 and U-ll,100A) on their estrogenic and antiestrogenic potencies and temporal patterns of effectiveness in the immature rat uterus. Changes in the chemical structures of these antiestrogens produce compounds with markedly different affinities for the uterine estrogen receptor as measured in an in vitro cell-free cytosol system; binding affinities relative to estradiol (100%) are: CI-628, 4% CI-680, 34% 94X1127 (94X), 222% U-ll,100A (UA), 6% and U-23,469 (U-23), 0.1%. Although all five antiestrogens (daily injections of 50 μg over three days) appear equally effective in stimulating 72 h uterine weight when given alone, or in blocking the estradiol-stimulated weight increase when given with estradiol, marked differences in their potencies are noted when the effects of the compounds are monitored beyond 24 h following a single injection. The compounds CI-628, CI-680 and UA (50 μg sc in saline), which have a methylated hydroxyl group (at the site analogous to the steroid position 3), show a prolonged maintenance of elevated levels of nuclear receptor (beyond 48 h) and elevated uterine weight (until 72 h); this correlates with a prolonged period of depressed cytoplasmic receptor levels (beyond 48 h) and prolonged uterine insensitivity to estrogen (beyond 36 h as monitored by 3 h wet weight response). In contrast, a single injection of 50 μg of 94X (having a free hydroxyl group) or U-23 (with a side chain and central ring different from UA) maintained nuclear receptor levels elevated for only 12 h (94X) or 36 h (U-23) and uterine weights declined after 36-48 h; cytoplasmic receptor levels remained depressed for only 12 h (94X) or 24 h (U-23) and then returned to control levels or above by 36 h. These latter compounds likewise evoked the shortest period of uterine insensitivity to estrogen (ineffective as antagonists by 36 h). Comparative studies with these five compounds indicate that they are effective as estrogen antagonists only so long as they maintain cytoplasmic receptor levels low, and that the magnitude of the responsiveness to estradiol after antiestrogen correlates with the extent of reappearance of cytoplasmic receptor. Thus, chemical modifications of antiestrogen structure have significant effects on their temporal patterns of effectiveness as estrogens and as estrogen antagonists.

AB - Studies were undertaken to ascertain the effects of structural modification of two well-known antiestrogens (CI-628 and U-ll,100A) on their estrogenic and antiestrogenic potencies and temporal patterns of effectiveness in the immature rat uterus. Changes in the chemical structures of these antiestrogens produce compounds with markedly different affinities for the uterine estrogen receptor as measured in an in vitro cell-free cytosol system; binding affinities relative to estradiol (100%) are: CI-628, 4% CI-680, 34% 94X1127 (94X), 222% U-ll,100A (UA), 6% and U-23,469 (U-23), 0.1%. Although all five antiestrogens (daily injections of 50 μg over three days) appear equally effective in stimulating 72 h uterine weight when given alone, or in blocking the estradiol-stimulated weight increase when given with estradiol, marked differences in their potencies are noted when the effects of the compounds are monitored beyond 24 h following a single injection. The compounds CI-628, CI-680 and UA (50 μg sc in saline), which have a methylated hydroxyl group (at the site analogous to the steroid position 3), show a prolonged maintenance of elevated levels of nuclear receptor (beyond 48 h) and elevated uterine weight (until 72 h); this correlates with a prolonged period of depressed cytoplasmic receptor levels (beyond 48 h) and prolonged uterine insensitivity to estrogen (beyond 36 h as monitored by 3 h wet weight response). In contrast, a single injection of 50 μg of 94X (having a free hydroxyl group) or U-23 (with a side chain and central ring different from UA) maintained nuclear receptor levels elevated for only 12 h (94X) or 36 h (U-23) and uterine weights declined after 36-48 h; cytoplasmic receptor levels remained depressed for only 12 h (94X) or 24 h (U-23) and then returned to control levels or above by 36 h. These latter compounds likewise evoked the shortest period of uterine insensitivity to estrogen (ineffective as antagonists by 36 h). Comparative studies with these five compounds indicate that they are effective as estrogen antagonists only so long as they maintain cytoplasmic receptor levels low, and that the magnitude of the responsiveness to estradiol after antiestrogen correlates with the extent of reappearance of cytoplasmic receptor. Thus, chemical modifications of antiestrogen structure have significant effects on their temporal patterns of effectiveness as estrogens and as estrogen antagonists.

UR - http://www.scopus.com/inward/record.url?scp=0017640570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017640570&partnerID=8YFLogxK

U2 - 10.1210/endo-100-5-1242

DO - 10.1210/endo-100-5-1242

M3 - Article

C2 - 849721

AN - SCOPUS:0017640570

VL - 100

SP - 1242

EP - 1251

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 5

ER -